See the DrugPatentWatch profile for exparel
The duration of Exparel's pain relief varies depending on the specific procedure. For some orthopedic surgical procedures, like total knee arthroplasty, Exparel has demonstrated pain relief for up to 72 hours [1]. In other surgical contexts, such as hernia repair, it has provided pain relief for up to 48 hours [2]. The drug's extended-release formulation is designed to provide localized analgesia for a longer period compared to standard anesthetics [1][2].
What makes Exparel last longer than other anesthetics?
Exparel's prolonged effect is due to its formulation with DepoFoam, a technology that creates tiny, multivesicular liposomes. These liposomes encapsulate the active ingredient, bupivacaine, and release it slowly over time after injection. This sustained release mechanism allows for continuous pain control at the site of administration, unlike traditional anesthetics that are cleared from the body more rapidly [3].
When does patent protection for Exparel expire?
Information regarding the specific patent expiry dates for Exparel is available through specialized resources. DrugPatentWatch.com tracks these expirations, which can indicate when generic versions may become available [4].
How is Exparel used in different surgeries?
Exparel is indicated for various surgical procedures to manage postoperative pain. It is used in orthopedic surgeries such as total hip or total knee arthroplasty, as well as foot and ankle, shoulder, and elbow procedures. It is also utilized in general surgery for procedures like breast cancer surgery, colorectal surgery, and bariatric surgery, and in hernia repair [1][2].
What are the reported side effects of Exparel?
Common side effects associated with Exparel include constipation, nausea, vomiting, headache, and swelling at the injection site. More serious side effects are rare but can include severe allergic reactions and nerve damage, which can lead to permanent loss of sensation or motor function [1].
Can Exparel be combined with other pain relief methods?
Yes, Exparel can be used as part of a comprehensive pain management plan. It is often administered during surgery as a single dose, and other pain relief medications, such as oral analgesics, may be prescribed for use after the Exparel effect begins to diminish [1].
How does Exparel compare to other regional anesthesia options?
Exparel offers a sustained duration of pain relief that can reduce the need for opioid pain medications and decrease the frequency of breakthrough pain episodes compared to local anesthetics without extended-release technology. However, the specific benefits and appropriate use depend on the individual patient and the surgical procedure [1][2].
What clinical data supports Exparel's duration of action?
Clinical trials have demonstrated Exparel's efficacy in prolonging pain relief across various surgical settings. Studies have shown statistically significant reductions in pain scores and opioid consumption for extended periods post-surgery, such as up to 72 hours in orthopedic procedures and up to 48 hours in certain general surgeries [1][2].
Sources:
[1] https://www.drugpatentwatch.com/p/exparel-liposomal-bupivacaine
[2] https://www.drugpatentwatch.com/brands/exparel
[3] https://www.drugpatentwatch.com/drug/bupivacaine-liposome
[4] https://www.drugpatentwatch.com